Tuniu Discloses Cash Dividend to Holders of ADSs NANJING, China, April 23, 2026 /PRNewswire/ — Tuniu Corporation (NASDAQ: TOUR) ("Tuniu"… CISION PRNewswireApril 23, 2026
Press ReleaseNow TV presents all award-winning films from the 44th Hong Kong Film Awards Best Actor and Best Actress winning titles now available (Release schedule attached)… CISION PRNewswireApril 23, 2026
Press ReleaseCISI Overseas Wealth Management Summit Held in Hong Kong, Spotlighting New Asset Allocation Opportunities amid Global Change HONG KONG, April 23, 2026 /PRNewswire/ — Against the backdrop of continued repricing… CISION PRNewswireApril 23, 2026
Press ReleaseViettel Post and FedEx Announce Strategic Partnership to Strengthen Cross-Border Logistics in Vietnam HANOI, Vietnam, April 23, 2026 /PRNewswire/ — Viettel Post, a member of… CISION PRNewswireApril 23, 2026
Ping An Releases 2025 Sustainability Report, Unveils "SIMPLE" Framework to Drive Long-Term Value Creation HONG KONG and SHANGHAI, April 23, 2026 /PRNewswire/ — Ping An Insurance (Group)… CISION PRNewswireApril 23, 2026
Mozambique President Visits Zoomlion Smart Industrial City During China State Visit CHANGSHA, China, April 23, 2026 /PRNewswire/ — Mozambique’s President Daniel Francisco Chapo toured the manufacturing… CISION PRNewswireApril 23, 2026
2026 ASCO | Mabwell to Present Latest Clinical Data on 9MW2821 Combined with Toripalimab for Urothelial Carcinoma in Oral and Poster Presentations SHANGHAI, April 23, 2026 /PRNewswire/ — Mabwell (688062.SH), an innovation-driven biopharmaceutical company… CISION PRNewswireApril 23, 2026
MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and… CISION PRNewswireApril 23, 2026
